Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
United States
Industries Focus
- Technology
- Healthcare
- Manufacturing
- Services
Investment Size:
2,000,000 to 15,000,000 USD
Investor Details Founded: 1999
Prism Capital is a Chicago-based private equity firm established in 1999, focusing on providing equity and mezzanine capital to lower middle market companies. The firm managed the Prism Opportunity Fund, a growth equity fund, and the Prism Mezzanine Fund, focusing on lower-middle market subordinated debt investments. ([prismfund.com](https://www.prismfund.com/?utm_source=openai))
The Prism Opportunity Fund invested in 14 companies, including SecurePipe, a digital security firm which merged with Trustwave; Celleration, a medical device company sold to Alliqua BioMedical; HighBeam Research, sold to Gale (part of Cengage Learning); SterilMed, sold to Great Hill Partners and Primus Capital; Banner Service Corp; and Fieldglass, sold to Madison Dearborn Partners. ([prismfund.com](https://www.prismfund.com/?utm_source=openai))
In 2011, the firm's partners began winding down the fund to pursue other interests, and they remain actively involved in winding down the remaining fund’s assets on behalf of their Limited Partners. ([prismfund.com](https://www.prismfund.com/?utm_source=openai))
Requirements
- Focus on lower middle market companies
- Interest in growth equity and mezzanine capital investments
- Preference for investments in the United States
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- SecurePipe
- Celleration
- HighBeam Research
- SterilMed
- Banner Service Corp
- Fieldglass
Mentioned In
-
$24.95
-
$19.95
-
$14.95
Claim this Investor
Are you an official representative of Prism Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim